(in millions $) | 29 Feb 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $8770.42 | $9689.06 | $15012.23 | |
Short term investments | $6612.36 | $6286.84 | $3454.24 | |
Net receivables | $6825.04 | $6729 | $6015 | $5997 |
Inventory | ||||
Total current assets | $22207.83 | $20571 | $20817 | $22990 |
Long term investments | $51563.49 | $48758.36 | $49604.49 | |
Property, plant & equipment | $4616.24 | $4276 | $4402 | $4361 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $73771.32 | $68335 | $68011 | $69719 |
Current liabilities | ||||
Accounts payable | $1924.87 | $1783 | $1618 | $1584 |
Deferred revenue | ||||
Short long term debt | $1873.05 | $1694.4 | $3256.79 | |
Total current liabilities | $15807.06 | $14642 | $13391 | $16176 |
Long term debt | $8572.86 | $7354 | $9228 | $9169 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $27180.33 | $25178 | $25051 | $27773 |
Shareholders' equity | ||||
Retained earnings | $45835.29 | $42457 | $44877 | $40225 |
Other shareholder equity | $2367 | $3099 | ||
Total shareholder equity | $46592.07 | $44384.95 | $44528.22 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $3369 | $3176 | $8898 | $5311 |
Short term investments | $3434.56 | $2758 | $1555 | |
Net receivables | $7071 | $6555 | $6759 | $7092 |
Inventory | ||||
Total current assets | $20571 | $18570 | $20040 | $15069 |
Long term investments | $56182.71 | $6279 | $3199 | |
Property, plant & equipment | $4276 | $4934 | $4975 | $4942 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $49580.39 | |||
Total investments | ||||
Total assets | $68335 | $72160 | $71173 | $58472 |
Current liabilities | ||||
Accounts payable | $1783 | $2106 | $1545 | $1213 |
Deferred revenue | ||||
Short long term debt | $5036.1 | $3598 | $552 | |
Total current liabilities | $14642 | $17452 | $16050 | $12842 |
Long term debt | $7354 | $9547 | $11042 | $11860 |
Total noncurrent liabilities | $17936.39 | |||
Total debt | ||||
Total liabilities | $25178 | $32025 | $29550 | $28544 |
Shareholders' equity | ||||
Retained earnings | $42457 | $40168 | $37334 | $32026 |
Other shareholder equity | $2367 | -$1 | $1550 | -$1011 |
Total shareholder equity | $42094.61 | $38959 | $29717 |
(in millions $) | 29 Feb 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $9745.8 | $7554 | ||
Cost of revenue | $2613.73 | |||
Gross Profit | $7132.07 | $5431 | ||
Operating activities | ||||
Research & development | $1925.86 | |||
Selling, general & administrative | $3040.5 | |||
Total operating expenses | $7589.96 | $3987 | ||
Operating income | $2155.84 | |||
Income from continuing operations | ||||
EBIT | $2155.84 | |||
Income tax expense | $690.87 | $369 | ||
Interest expense | -$11 | |||
Net income | ||||
Net income | $1126.25 | $3454 | ||
Income (for common shares) | $1126.25 |
(in millions $) | 31 Jan 2024 | 2 Mar 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $31207 | $32334.54 | $27842 | $27338 |
Cost of revenue | $9358.9 | $7723 | $7885 | |
Gross Profit | $22603 | $22975.64 | $20119 | $19453 |
Operating activities | ||||
Research & development | $6458.53 | $5180 | $4454 | |
Selling, general & administrative | $11537.58 | $9544 | $8462 | |
Total operating expenses | $16101 | $27355 | $22481 | $20911 |
Operating income | $4979.54 | $5361 | $6427 | |
Income from continuing operations | ||||
EBIT | $5036.1 | $5361 | $6427 | |
Income tax expense | $1741 | $1447.57 | $1467 | $1938 |
Interest expense | -$145 | -$160 | -$255 | |
Net income | ||||
Net income | $6139 | $2392.36 | $5263 | $5145 |
Income (for common shares) | $2392.36 | $5263 | $5145 |
(in millions $) | 29 Feb 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
---|---|---|---|---|
Net income | $1126.25 | |||
Operating activities | ||||
Depreciation | $405.69 | |||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $2328.16 | |||
Investing activities | ||||
Capital expenditures | -$232.73 | |||
Investments | ||||
Total cash flows from investing | -$2025.33 | $906 | $2907 | $6364 |
Financing activities | ||||
Dividends paid | -$2395 | -$2395 | -$2395 | |
Sale and purchase of stock | ||||
Net borrowings | -$4936.87 | |||
Total cash flows from financing | -$1350.66 | -$7734 | -$6773 | -$4259 |
Effect of exchange rate | -$388 | -$128 | -$212 | |
Change in cash and equivalents | $8770.42 | -$883 | $370 | $5134 |
(in millions $) | 31 Jan 2024 | 2 Mar 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Net income | $2392.36 | $5263 | $5145 | |
Operating activities | ||||
Depreciation | $1985.95 | $1775 | $1532 | |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $5915.95 | $6208 | $7194 | |
Investing activities | ||||
Capital expenditures | -$915.46 | -$825 | -$816 | |
Investments | -$1139 | -$1800 | ||
Total cash flows from investing | $906 | $697.6 | -$3055 | -$2986 |
Financing activities | ||||
Dividends paid | -$2395 | -$2182 | -$1864 | |
Sale and purchase of stock | ||||
Net borrowings | $2166.11 | -$646 | -$676 | |
Total cash flows from financing | -$7734 | -$6637.64 | -$54 | -$3997 |
Effect of exchange rate | -$388 | $488 | -$214 | |
Change in cash and equivalents | -$883 | -$392.48 | $3587 | -$4 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | 3.17% |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.40 |
Quick ratio | 1.40 |